 |
Prabagar Balakrishnan, PhD
Postdoctoral Associate Email: prabagar.balakrishnan@stonybrookmedicine.edu |
Dr. Balakrishnan received his Bachelor of Pharmacy from Tamilnadu Dr. MGR Medical University, India and his PhD in Pharmaceutical Sciences from Yeungnam University, South Korea. During his postdoctoral study at Seoul National University, he investigated the multidrug resistance and antitumor effect of docetaxle nanoparticles and developed several formulations for hydrophobic drugs. He has also served as a Senior Scientist for Utah-Inha DDS and the Advanced Therapeutic Research Center in South Korea.
Dr. Balakrishnan is currently working on the development of novel nano-formulations for the topical delivery of our novel drugs and assessment of their PK, efficacy and safety.
Selected Publications
- Balakrishnan P, Park EK, Song CK, Ko HJ, Hahn TW, Song KW, Cho HJ. Carbopol-incorporated thermoreversible gel for intranasal drug delivery. Molecules (Basel, Switzerland). 2015;20(3):4124-35.
- Balakrishnan P, Song CK, Jahn A, Cho HJ. Ceramide and N,N,N-Trimethylphytosphingosine-Iodide (TMP-I)-Based Lipid Nanoparticles for Cancer Therapy. Pharmaceutical Research. 2016;33(1):206-16.
- Balakrishnan P, Song CK, Cho HJ, Yang SG, Kim DD, Yong CS, Choi HG. Inclusion complex effect on the bioavailability of clotrimazole from poloxamer-based solid suppository. Archives of Pharmacal Research. 2012;35(7):1169-75.
- Cho HJ, Balakrishnan P, Park EK, Song KW, Hong SS, Jang TY, Kim KS, Chung SJ, Shim CK, Kim DD. Poloxamer/cyclodextrin/chitosan-based thermoreversible gel for intranasal delivery of fexofenadine hydrochloride. Journal of Pharmaceutical Sciences. 2011;100(2):681-91.
- Park MJ, Balakrishnan P, Yang SG. Polymeric nanocapsules with SEDDS oil-core for the controlled and enhanced oral absorption of cyclosporine. International Journal of Pharmaceutics. 2013;441(1-2):757-64.
For a complete list of publications, Click Here.
